These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38697465)

  • 1. High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial.
    Picod A; Nordin H; Jarczak D; Zeller T; Oddos C; Santos K; Hartmann O; Herpain A; Mebazaa A; Kluge S; Azibani F; Karakas M
    J Card Fail; 2024 Apr; ():. PubMed ID: 38697465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
    Blet A; Deniau B; Santos K; van Lier DPT; Azibani F; Wittebole X; Chousterman BG; Gayat E; Hartmann O; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF; Mebazaa A;
    Crit Care; 2021 Feb; 25(1):61. PubMed ID: 33588925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial.
    Takagi K; Blet A; Levy B; Deniau B; Azibani F; Feliot E; Bergmann A; Santos K; Hartmann O; Gayat E; Mebazaa A; Kimmoun A
    Eur J Heart Fail; 2020 Feb; 22(2):279-286. PubMed ID: 31472039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock:
    van Lier D; Picod A; Marx G; Laterre PF; Hartmann O; Knothe C; Azibani F; Struck J; Santos K; Zimmerman J; Bergmann A; Mebazaa A; Pickkers P
    Front Med (Lausanne); 2022; 9():1058235. PubMed ID: 36530868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial.
    Karakas M; Akin I; Burdelski C; Clemmensen P; Grahn H; Jarczak D; Keßler M; Kirchhof P; Landmesser U; Lezius S; Lindner D; Mebazaa A; Nierhaus A; Ocak A; Rottbauer W; Sinning C; Skurk C; Söffker G; Westermann D; Zapf A; Zengin E; Zeller T; Kluge S
    Lancet Respir Med; 2022 Mar; 10(3):247-254. PubMed ID: 34895483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl Amino-Peptidase 3 (DPP3) as an Early Marker of Severity in a Patient Population with Cardiogenic Shock.
    Innelli P; Lopizzo T; Paternò G; Bruno N; Radice RP; Bertini P; Marabotti A; Luzi G; Stabile E; Di Fazio A; Pittella G; Paternoster G
    Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.
    Deniau B; Rehfeld L; Santos K; Dienelt A; Azibani F; Sadoune M; Kounde PR; Samuel JL; Tolpannen H; Lassus J; Harjola VP; Vodovar N; Bergmann A; Hartmann O; Mebazaa A; Blet A
    Eur J Heart Fail; 2020 Feb; 22(2):290-299. PubMed ID: 31472040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
    Wenzl FA; Bruno F; Kraler S; Klingenberg R; Akhmedov A; Ministrini S; Santos K; Godly K; Godly J; Niederseer D; Manka R; Bergmann A; Camici GG; von Eckardstein A; Stähli B; Muller O; Roffi M; Räber L; Lüscher TF
    Eur Heart J; 2023 Oct; 44(38):3859-3871. PubMed ID: 37632743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study.
    van Lier D; Beunders R; Kox M; Pickkers P
    Eur J Anaesthesiol; 2022 Apr; 39(4):342-351. PubMed ID: 35102040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohort.
    van Lier D; Beunders R; Kox M; Pickkers P
    J Crit Care; 2023 Dec; 78():154383. PubMed ID: 37482013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.
    Gombert A; Barbati M; Kotelis D; Simon TP; Breuer T; Hartmann O; Santos K; Bergmann D; Schulte J; Marx G; Jacobs M; Stoppe C
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):750-757. PubMed ID: 33236058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality.
    Frigyesi A; Lengquist M; Spångfors M; Annborn M; Cronberg T; Nielsen N; Levin H; Friberg H
    J Intensive Care; 2021 Aug; 9(1):52. PubMed ID: 34429159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study.
    van Lier D; Deniau B; Santos K; Hartmann O; Dudoignon E; Depret F; Plaud B; Laterre PF; Mebazaa A; Pickkers P
    ERJ Open Res; 2023 Jan; 9(1):. PubMed ID: 36628268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory dipeptidyl peptidase 3 (cDPP3) is a potential biomarker for early detection of secondary brain injury after aneurysmal subarachnoid hemorrhage.
    Neumaier F; Stoppe C; Veldeman M; Weiss M; Simon T; Hoellig A; Marx G; Clusmann H; Albanna W
    J Neurol Sci; 2021 Mar; 422():117333. PubMed ID: 33549902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome.
    Thorgeirsdóttir B; Levin H; Spångfors M; Annborn M; Cronberg T; Nielsen N; Lybeck A; Friberg H; Frigyesi A
    Resuscitation; 2021 Jun; 163():108-115. PubMed ID: 33930500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
    Garcia B; Ter Schiphorst B; Santos K; Su F; Dewachter L; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Uba T; Hartmann O; Picod A; Azibani F; Callebert J; Goldman S; Annoni F; Favory R; Vincent JL; Creteur J; Taccone FS; Mebazaa A; Herpain A
    Intensive Care Med Exp; 2024 Jun; 12(1):53. PubMed ID: 38849640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Goel K; Shah P; Jones BM; Korngold E; Bhardwaj A; Kar B; Barker C; Szerlip M; Smalling R; Dhoble A
    Eur Heart J; 2023 Sep; 44(33):3181-3195. PubMed ID: 37350747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
    Dépret F; Amzallag J; Pollina A; Fayolle-Pivot L; Coutrot M; Chaussard M; Santos K; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Benyamina M; Guillemet L; Deniau B; Mebazaa A; Gayat E; Farny B; Textoris J; Legrand M;
    Crit Care; 2020 Apr; 24(1):168. PubMed ID: 32321571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.